Your heart in focus - A cooperation between Cardisio and medneo
The heart is an important and central organ. With up to 100,000 beats per day, it performs at its peak every day. Heart disease, in turn, affects the entire body. Statistically, in every third man and every fifth woman the heart does not work as it should.
Interpreting heart problems in good time is difficult for those affected, as the complaints are often ambiguous, frequently appearing in alternation and then disappearing again. In order to detect serious heart problems at an early stage and to be able to treat them as quickly as possible, the companies medneo and Cardisio are now cooperating with each other in a unique way.
The future of heart health
Cardisiography is an AI-based vector cardiography that is as easy to use as an ECG, and shows whether the heart is healthy or diseased after about 5 minutes. Fine diagnostics using cardio-MRI (cardiac MRI) detects a wide variety of diseases of the heart even in the early stages and problems down to the tissue. By combining the two diagnostic procedures, the diseases can be detected as quickly as possible and subsequently treated.
"Over 40,000 people in Germany die of a heart attack every year. Many of these would be preventable with good cardiac precautions. However, most patients do not know that their symptoms, such as fatigue or shortness of breath, are due to heart disease and go to the doctor too late," knows cardiologist and Head of Cardiac Imaging PD Dr. Henning Steen. "This is exactly why we developed Cardisiography," confirms Klaus Tenderich, Co-Founder of Cardisio: "With our examination, we quickly determine: Is the heart healthy or not. This is particularly important in view of the fact that the usual ECG examinations have virtually no significance in detecting structural or ischemic heart disease. Patients examined in this way usually delude themselves into thinking that their hearts are fine. Unfortunately, this is often not true." The diagnostics experts at medneo also immediately saw the potential: "Once it has been established that it is the heart, the cooperating doctors can quickly find the cause thanks to our modern imaging procedures. This can then be treated in a very targeted manner," says Daniel Hefel, Managing Director of medneo.
Diagnosis in just a few days
This approach is the future of heart health, the experts are certain: "In conventional diagnostics, it can take several months before patients know how their heart is doing. Now it can be clarified within 2-3 days and, if necessary, therapy can be initiated. A real milestone!", explains PD Henning Steen, MD.
medneo is an innovative company headquartered in Berlin that specializes in Radiology as a Service - a new operator model for radiology - for the outpatient and inpatient sector. In doing so, medneo transforms a classic hardware business into a service business. Founded in 2011, the company offers diagnostics-on-demand to physicians, hospitals and research institutions in Germany, the UK and Switzerland. medneo delivers clinical images instead of equipment - a revolutionary idea that is still the key to its success today. Furthermore, medneo is additionally on the road with 9 mobile MRI trailers in Germany and the UK.
Cardisio GmbH was founded in 2016 in Frankfurt am Main and operates locations in Berlin, Mülheim an der Ruhr and in the USA in San Francisco (California/USA). The team at Cardisio is committed to the early detection of heart disease. For this purpose, a novel system has been developed, the Cardisiography. This examination method detects ischemic and structural heart disease quickly, accurately and non-invasively. Cardisiography is now used in many practices and clinics, paving the way for simple and reliable early detection. In addition to the locations mentioned above, Cardisio consists of a team of international distributors on different continents.